The government has previously committed to introducing several new family-friendly rights following numerous consultations over the last few years.
These include: neonatal leave and pay; carer's leave; and extending redundancy protection for pregnant women and new parents.
The government confirmed it would implement these reforms in the long-awaited Employment Bill, first announced in the Queen's speech back in 2019.
However, the Employment Bill was not referred to in the Queen's speeches in both May 2021 and May 2022 therefore it remains unclear when these reforms will be
prioritised.
Nevertheless, at this stage, it is helpful for pharmacy business owners and managers to have an understanding of the direction of travel when it comes to family
friendly rights in the workplace.
The NHS has launched plans to expand pioneering subscription-style drug contracts to develop lifesaving antibiotics of the future.
It is building on its world-first pilot to incentivise the pharmaceutical industry to develop new antibiotics that could be offered to NHS patients when they
need them the most.
The consultation has launched almost a year to the day that contracts for two superbug-busting drugs were rolled out as part of a world-first pilot.
Cefiderocol and ceftazidime-avibactam, new antibiotics manufactured by Shionogi and Pfizer respectively, were awarded world-first subscription contracts which
provided the companies with a fixed annual fee based primarily on the availability of the drugs and their value to the NHS, as opposed to the volumes used.
By breaking the link between the payments companies receive and the number of their antibiotics prescribed, the NHS is removing any incentive to overuse antibiotics,
decreasing the risk of life-threatening infections, such as sepsis and pneumonia, becoming resistant to treatment.
In its first, the National Institute for Health and Care Excellence (NICE) has recommended the use of Pre Exposure Prophylaxis (PrEP) to treat people at the
highest risk of catching HIV.
The announcement comes along with a consultation on draft guideline by NICE on reducing sexually transmitted infections.
NICE's recommendation is backed up by the government's HIV Action Plan to hit zero new transmissions of HIV by 2030.
The pill prevents HIV by stopping the virus from crossing into the healthy cells and replicating.
According to the UK PROUD study, PrEP reduced the risk of HIV infection by 86 per cent for men who have sex with men.
However, people taking the pill must also get regular HIV testing and STI screening done every three months.
A recent Pharmacists' Defence Association (PDA) survey revealed that 80 per cent of its member working in the NHS in England, Wales, and Northern Ireland
rejected the NHS pay award.
"For the first time in the history of our union, members have told us they are so angry that they would not rule out industrial action in conjunction with other
NHS unions," said Paul Moloney, PDA Union national officer.
"It is important that, whoever is to lead the government, they listen to this message and act now to ensure our members and others in the NHS do not face swinging
cuts to their standard of living."
PDA members were asked whether they would support industrial action if they had rejected the award and if other NHS unions would be taking industrial action. 58 per
cent of those responding said they would support the PDA Union taking industrial action if members of other unions were also planning to take action on this issue.
For now, however, the PDA Union will wait for other unions to publish the outcomes of their own consultations. As a union dedicated to representing the needs of only
pharmacists, the PDA has been able to quickly survey members immediately after the pay award was announced.
In partnership with the pharmaceutical company Boehringer Ingelheim, Leeds Teaching Hospitals Trust (LTHT) has recently established an innovative
cardiometabolic clinic.
The clinic focuses on reducing cardiovascular risk in people with diabetes who have recently been discharged from LTHT following a heart attack. It is delivered jointly by the cardiology department at Leeds General Infirmary and the diabetes services at the Trust.
This is a patient-centred approach to reducing that risk, with pharmacist-delivered clinics scheduled for six to eight weeks after the heart attack.
Stephen Wheatcroft, Professor of Cardiometabolic Medicine and Consultant Cardiologist at LTHT, said: "This is an exciting and innovative development, one of the
first in the country. Previously, Type 2 diabetic patients presenting with heart issues would have been treated by two separate specialty teams. This is the first time there has been a specific clinic combining the cardiac and diabetes team working together.
"We aim to reduce the risk for patients, with earlier multidisciplinary hospital care, to help discharged patients achieve better diabetes control, through improved medication support and optimisation, reducing the need for further treatment and future hospital stays. Overall, it will mean a better patient experience, with improved monitoring and information about treatment options, along with a reduction in waiting times for review in a specialist clinic."
Scotland has become the world's first country to introduce a simple blood test for Type 1 diabetes patients, enabling them to stop taking insulin by improving the accuracy of diagnosis.
The routine C-peptide test, introduced today (November 1), will allow doctors to know how much insulin someone with diabetes is making themselves.
The roll-out of test follows a two-year pilot study in NHS Lothian led by diabetes and endocrinology consultant Professor Mark Strachan.
Strachan said: "C-peptide helps diabetes specialists make a more accurate diagnosis of the cause of diabetes, and that means we can get people on the most appropriate treatment. In some instances, C-peptide testing allowed people to stop very long-standing insulin therapy; this can be life-transforming."
An ever-increasing emphasis is being placed on getting and staying fit and mobile, whatever your age, with good reason. Regular aerobic exercise (physical
activity which gets the heart beating faster) helps patients to:
Reduce or maintain body weight
Reduce the risk of heart disease, strokes and diabetes
Control blood sugar (helpful for diabetics)
Maintain mobility and muscle strength, allowing daily activities to be undertaken more easily
Improve mood, physical activity can be beneficial for everyone.
However, injuries sometimes happen during exercise or everyday life. Collectively, injuries to tendons, ligaments and/or skeletal muscle, are referred to as
musculoskeletal soft tissue injuries. Post pandemic pharmacists are now the first port of call for many seeking to self-treat so it is important that information,
advice and a wide range of treatment options are available.
While the precise incidence and prevalence of such disorders are difficult to define, they are known to be the most common rheumatic causes of sickness absences
from work. Indeed, soft tissue complaints account for up to 59 per cent of new patient referrals to rheumatology practice and up to 15 per cent of consultations in
primary care.
Ankle injuries are very common with an estimated incidence of one per 100,000 population per day. They account for about one in five of all sports related injuries.
The majority of ankle injuries are moderate ligament sprains. With appropriate treatment the majority of patients should be able to return to normal activities
within a few weeks.
In response to new research that revealed inequality in menopause support with 51 per cent of women from black, Asian and minority ethnic backgrounds,
Holland & Barrett, the UK's leading health and wellness retailer, has decided to continue its menopause campaign work to make "every menopause matter".
A quarter of women (26 per cent) from minority ethnic communities say they find it difficult to access menopause support relevant to their specific backgrounds.
Alongside support from Olympian and menopause campaigner, Michelle Griffith Robinson and expert, Meera Bhogal, the retailer is launching several new initiatives
to make its information and support on menopause more inclusive by offering more diverse and personalised advice and content, tailored to different needs.
Almost a third (31 per cent) believe being able to speak to a female healthcare professional of the same ethnicity as them would have made a difference to their
menopause experience. Fifteen per cent go as far as saying that communicating in their native language would have made a positive difference.
Based on these findings, Holland and Barrett is the first retailer to launch a free, multi-language menopause online consultation service. The service will
see trained H&B menopause advisors offering guidance and symptom support in multiple languages, starting with Hindi, Urdu, Gujarati and Punjabi.
HRA Pharma is celebrating the 1st anniversary of Hana, the first type of daily oral contraception available in the UK without a prescription.
The launch of Hana in 2021 followed the historic decision of the Medicines and Healthcare products Regulatory Agency (MHRA) to grant a marketing authorisation
and marked a significant step forward in the women's contraception category.
The company reports that pharmacists have embraced the reclassification and have found merit in using emergency contraception consultations as an opportunity to
educate women on their over-the-counter contraception options.
Alison Slingsby, innovations project manager at HRA Pharma, commented: "We have been delighted with Hana's reception - within weeks of launch, it quickly became
the best-selling mini-pill without prescription, with more than 95 per cent market share, and has maintained this market leading position ever since. We previously
had the experience of switching emergency contraceptive ellaOne to a P medicine, Hana is on track to match and eventually exceed the ellaOne volumes.
The Department of Health and Social Care (DHSC) has introduced a new 'swap to stop' scheme to encourage one million smokers to swap cigarettes for vapes in
England.
As part of the world-first national scheme, almost 1 in 5 of all smokers in England will be provided with a vape starter kit alongside behavioural support to help
them quit the habit as part of a series of new measures to help the government meet its ambition of being smokefree by 2030 - reducing smoking rates to 5% or less.
Local authorities will also be invited to take part in the scheme later this year and each will design a scheme which suits its needs, including deciding which
populations to prioritise.
Health Minister Neil O'Brien announced on Tuesday (11 April) that pregnant women will be offered financial incentives to help them stop smoking. This will involve
offering vouchers, alongside behavioural support, to all pregnant women who smoke by the end of next year.
The government will also consult on introducing mandatory cigarette pack inserts with positive messages and information to help people to quit smoking.
It has also announced a formation of new 'illicit vapes enforcement squad' to regulate and tackle the sales of illegal vapes to under 18s.
Reena Mehta, consultant pharmacist in the Critical Care team at NHS King's College Hospital, has been announced as chair of the Learning Division for the
Intensive Care Society.
Mehta took up the post with effect from 8th April, and is the first pharmacist to hold the role of Chair of the Learning Division within the Society.
"It is a privilege to be part of the Society and support its life-saving work to enhance our understanding of critical illness and deliver better care to patients,"
"The intensive care community is made up of multiple professions, each playing a vital role within the critical care team, and I am extremely proud to be the first
pharmacist appointed to this important role."
In her role as chair of the Learning Division, Mehta will oversee the content of the Society's study days and be responsible for exploring new opportunities for the
Intensive Care Society to provide training for our multi professional intensive care community.
The Department of Health and Social Care (DHSC) launched a new Innovative Medicines Fund on Tuesday (June 7) under which £340 million has been made available
to purchase potentially life-saving drugs early.
This will allow NHS patients in England to have early access to potentially life-saving and cutting-edge treatments
Health secretary Sajid Javid said: "I want NHS patients to be the first in the world to access the most promising and revolutionary treatments that could extend or
save their lives.
"The launch of the Innovative Medicines Fund delivers another manifesto pledge and will fast-track cutting-edge medicines to adults and children to give people
renewed hope for a better future."
A total of £680 million has been ringfenced for the Innovative Medicines Fund and Cancer Drugs Fund - £340 million each - to fast-track medicines to NHS patients.
DHSC said: "The Innovative Medicines Fund will provide quick access to novel treatments, including potentially lifesaving gene therapies for serious conditions with
few treatment options. It often takes longer for pharmaceutical companies to collect data on a medicine's clinical and cost effectiveness for rare diseases due to
the smaller patient cohort.
Kamila Hawthorne, the chair of the Royal College of General Practitioners (RCGP) Council, was honoured with the GG2 Woman of the Year Award at the annual
GG2 Leadership and Diversity Awards, held at the Park Plaza Hotel on Tuesday, 5 March.
Hawthorne has been a practitioner and a mentor to young GPs for almost 35 years, and has led pioneering research projects focusing on health inequalities,
diabetes and heart disease. She has been recognised twice as GP of the Year for her work with minority ethnic communities.
Professor Kiran Patel, Group Chief Medical Officer at University Hospitals Birmingham NHS Foundation Trust, was named the GG2 Man of the Year Award.
Apart from being a sought-after cardiologist and consultant, Patel also possesses a wealth of experience in managerial roles. He has done a lot of work in
addressing health inequalities, and notably, in 2020, he prescribed the very first COVID-19 vaccine.